 |
The Journal of Neuroscience, August 13, 2003, 23(19):7269-7280
Previous Article | Next Article 
Hypertrophic Neuropathies and Malignant Peripheral Nerve Sheath Tumors in Transgenic Mice Overexpressing Glial Growth Factor 3 in Myelinating Schwann Cells
Richard P. H. Huijbregts,1
Kevin A. Roth,1
Robert E. Schmidt,2 and
Steven L. Carroll1
1Division of Neuropathology, Department of
Pathology, The University of Alabama at Birmingham, Birmingham, Alabama
35294-0017, and 2Division of Neuropathology,
Department of Pathology, Washington University School of Medicine, St. Louis,
Missouri 63110
The neuregulin-1 (NRG-1) family of growth and differentiation factors
exerts a variety of effects on Schwann cells and their precursors during
nervous system development; however, NRG-1 effects on adult Schwann cells are
poorly defined. Several lines of evidence suggest that NRG-1 actions on adult
Schwann cells are distinct from those observed during development. To test
this hypothesis, we generated transgenic mice overexpressing the NRG-1 isoform
glial growth factor 3 (GGF 3) in myelinating Schwann cells [protein
zero (P0)GGF 3 mice]. P0-GGF 3 mice develop
resting tremors, gait abnormalities, decreased hindlimb strength, and
paralysis by 7 months of age. Sciatic nerves from these animals show a
hypertrophic neuropathy characterized by demyelination, remyelination, and
"onion bulb" formation. Development of this hypertrophic
neuropathy is preceded by Schwann cell hyperplasia that is prominent in
1-month-old mice and present but decreased in 2- and 4-month-old animals.
P0-GGF 3 mice also develop peripheral ganglion-associated
malignant peripheral nerve sheath tumors. Motor, sensory, and sympathetic
ganglia from 1-, 2-, and 4-month-old P0-GGF 3 mice uniformly
contain intraganglionic, likely preneoplastic, Schwann cell proliferations.
Examination of bromodeoxyuridine incorporation and caspase-3 activation in
sciatic nerves and trigeminal ganglia indicates that Schwann cell hyperplasia
in P0-GGF 3 mice reflects increased proliferation rather than
decreased apoptosis. These observations are consistent with the hypothesis
that GGF 3 induces proliferation of adult Schwann cells and demyelination
of peripheral nerve axons. Furthermore, overexpression of this NRG-1 isoform
frequently induces neoplastic Schwann cell proliferation within PNS ganglia,
suggesting that NRG-1 may contribute to human Schwann cell neoplasia.
Key words: Schwann cell; erbB receptor; schwannoma; neuropathy; neuregulin; glial growth factor
Received Dec. 17, 2002;
revised Jun. 3, 2003;
accepted Jun. 6, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
R. T. Dobrowsky, S. Rouen, and C. Yu
Altered Neurotrophism in Diabetic Neuropathy: Spelunking the Caves of Peripheral Nerve
J. Pharmacol. Exp. Ther.,
May 1, 2005;
313(2):
485 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Guertin, D. P. Zhang, K. S. Mak, J. A. Alberta, and H. A. Kim
Microanatomy of Axon/Glial Signaling during Wallerian Degeneration
J. Neurosci.,
March 30, 2005;
25(13):
3478 - 3487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Pearson Jr. and S. L. Carroll
ErbB Transmembrane Tyrosine Kinase Receptors Are Expressed by Sensory and Motor Neurons Projecting into Sciatic Nerve
J. Histochem. Cytochem.,
October 1, 2004;
52(10):
1299 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Li, S. Ahmed, and J. A. Loeb
Development of an Autocrine Neuregulin Signaling Loop with Malignant Transformation of Human Breast Epithelial Cells
Cancer Res.,
October 1, 2004;
64(19):
7078 - 7085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Esper and J. A. Loeb
Rapid Axoglial Signaling Mediated by Neuregulin and Neurotrophic Factors
J. Neurosci.,
July 7, 2004;
24(27):
6218 - 6227.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|